Phase 2 Kidney Cancer Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You have been diagnosed with kidney cancer (renal cell carcinoma) that has come back and spread to other parts of the body, confirmed by a PET/CT scan or similar full-body imaging.
• You have 5 or fewer areas where the cancer has spread that can all be fully targeted with radiation therapy; or you have more than 5 areas of spread, but at least 3 of them are suitable for radiation therapy as assessed by the medical team.
• You are between 18 and 80 years old.
• Your doctors expect you to live for at least 12 weeks.
• Your cancer can be measured using standard medical imaging guidelines (confirm with trial site).
• You are reasonably active and able to care for yourself, with only mild limitations on daily activity at most (confirm with trial site).

Who may not be able to join:

• You have previously received certain immunotherapy treatments (anti-PD-1 or PD-L1 drugs) or have had radiation therapy in the past.
• You have taken steroid medications or other drugs that suppress the immune system in the 14 days before starting treatment.
• You have an autoimmune disease (a condition where your immune system attacks your own body).
• You have a history of any other type of cancer.
• You have had surgery within 28 days before starting treatment.
• You have a known allergy to any of the ingredients in the study drug.

Important: Always verify eligibility with the trial site directly before applying.